Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 6, 2005, Pages 2372-2377

  Bosnar, Martina ^a   Kelnerić, Željko ^a   Munić, Vesna ^a   Eraković, Vesna ^a   Parnham, Michael J ^a  

^a PLIVA Research Institute Ltd   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CETHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; KETOLIDE; MACROLIDE; TELITHROMYCIN;

ARTICLE; BONE MARROW CELL; CELL LINE; CELL SPECIFICITY; CELL STRAIN; CELL TRANSPORT; CONTROLLED STUDY; DRUG RELEASE; DRUG TRANSPORT; DRUG UPTAKE; HOST CELL; MONOCYTE; NONHUMAN; PHAGOCYTE; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CELL LINE; CLARITHROMYCIN; DOGS; EPITHELIAL CELLS; ERYTHROMYCIN; HUMANS; KETOLIDES; MACROLIDES; MICE; NEUTROPHILS; PHAGOCYTES;

EID: 19544366269     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.6.2372-2377.2005     Document Type: Article

References (36)

1. Abdelghaffar, H., A. Soukri, C. Babin-Chevaye, and M.-T. Labro. 2003. Interaction of macrolides and ketolides with the phagocytic cell line PLB-985. J. Chemother. 15:350-356.
2. Blais, J., D. Beauchamp, and S. Chamberland. 1994. Azithromycin uptake and intracellular accumulation by Toxoplasma gondii-infected macrophages. J. Antimicrob. Chemother. 34:371-382.
3. Bright, G. M., A. A. Nagel, J. Bordner, K. A. Desai, J. N. Dibrino, J. Nowakowska, L. Vincent, R. M. Watrous, F. C. Sciavolino, A. R. English, J. A. Retsema, M. R. Anderson, L. A. Brennan, R. J. Borovoy, C. R. Cimochowski, J. A. Faiella, A. E. Girard, D. Girard, C. Herbert, M. Manousos, and R. Mason. 1988. Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a- homoerythromycin A derivatives; a new class of macrolide antibiotics, the azalides. J. Antibiot. 41:1029-1047.
4. Carlier, M. B., I. Garcia-Luque, J. F. Montenez, P. M. Tulkens, and J. Piret. 1994. Accumulation, release and subcellular localization of azithromycin in phagocytic and non-phagocytic cells in culture. Int. J. Tissue React. 16:211-220.
5. Conte, J. E., Jr., J. A. Golden, J. Kipps, and E. Zurlinden. 2004. Steady-state plasma and intrapulmonary pharmacokinetics and pharmacodynamics of cethromycin. Antimicrob. Agents Chemother. 48:3508-3515.
6. Denis, A., C. Agouridas, J. M. Auger, Y. Benedetti, A. Bonnefoy, F. Bretin, J. F. Chantot, A. Dussarat, C. Fromentin, S. G. D'Ambrieres, S. Lachaud, P. Laurin, O. Le Martret, V. Loyau, N. Tessot, J. M. Pejac, and S. Perron. 1999. Synthesis and antibacterial activity of HMR 3647, a new ketolide highly potent against erythromycin-resistant and susceptible pathogens. Bioorg. Med. Chem. Lett. 9:3075-3080.
7. Foulds, G., R. M. Shepard, and R. B. Johnson. 1990. The pharmacokinetics of azithromycin in human serum and tissues. J. Antimicrob. Chemother. 2S(Suppl. A):73-82.
8. Frank, M. O., G. W. Sullivan, H. T. Carper, and G. L. Mandell. 1992. In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes. Antimicrob. Agents Chemother. 36:2584-2588.
9. Gladue, R. P., G. M. Bright, R. E. Isaacson, and M. F. Newborg. 1989. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob. Agents Chemother. 33:277-282.
10. Hall, I. H., U. E. Schwab, E. S. Ward, J. D. Butts, E. T. Wolford, and T. J. Ives. 2002. Disposition and intracellular activity of azithromycin in human THP-1 acute monocytes. Int. J. Antimicrob. Agents 20:348-360.
11. Hand, W. L., and D. L. Hand. 2001. Characteristics and mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes. Int. J. Antimicrob. Agents 18:419-425.
12. Idid, S. Z., N. R. Damanhury, Z. Ismail, and M. Arif. 2000. The absorption and distribution pattern of azithromycin in mice determined by the agar diffusion bioassay method. Asia Pacific J. Pharmacol. 14:79-82.
13. Ishiguro, M., H. Koga, S. Kohno, T. Hayashi, K. Yamaguchi, and M. Hirota. 1989. Penetration of macrolides into human polymorphonuclear leucocytes. J. Antimicrob. Chemother. 24:719-729.
14. Kees, F., M. Wellenhofer, and H. Grobecker. 1995. Serum and cellular pharmacokinetics of clarithromycin 500 mg q.d. and 250 mg b.i.d. in volunteers. Infection 23:168-172.
15. Kroboth, P. D., A. Brown, J. A. Lyon, F. J. Kroboth, and R. P. Juhl. 1982. Pharmacokinetics of single-dose erythromycin in normal and alcoholic liver disease subjects. Antimicrob. Agents Chemother. 21:135-140.
16. Labro, M. T. 1996. Intracellular bioactivity of macrolides. Clin. Microbiol. Infect. 1(Suppl. 1):S24-S30.
17. Labro, M. T. 1997. Effects of macrolides on leukocytes and inflammation, p. 101-116. In S. H. Zinner, L. S. Young, J. F. Acar, and H. C. Neu (ed.), Expanding indications for the new macrolides, azalides, and streptogramins. Marcel Dekker, Inc., New York, N.Y.
18. Labro, M. T., H. Abdelghaffar, and C. Babin-Chevaye. 2004. Interaction of the new ketolide ABT-773 (cethromycin) with human polymorphonuclear neutrophils and the phagocytic cell line PLB-985 in vitro. Antimicrob. Agents Chemother. 48:1096-1104.
19. Ma, Z., R. F. Clark, A. Brazzale, S. Wang, M. J. Rupp, L. Li, G. Griesgraber, S. Zhang, H. Yong, L. T. Phan, P. A. Nemoto, D. T. Chu, J. J. Plattner, X. Zhang, P. Zhong, Z. Cao, A. M. Nilius, V. D. Shortridge, R. Flamm, M. Mitten, J. Meulbroek, P. Ewing, J. Alder, and Y. S. Or. 2001. Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogens. J. Med. Chem. 44:4137-4156.
20. Mandell, G. L., and E. Coleman. 2001. Uptake, transport, and delivery of antimicrobial agents by human polymorphonuclear neutrophils. Antimicrob. Agents Chemother. 45:1794-1798.
21. Martin, J. R., P. Johnson, and M. F. Miller. 1985. Uptake, accumulation, and egress of erythromycin by tissue culture cells of human origin. Antimicrob. Agents Chemother. 27:314-319.
22. Miossec-Bartoli, C., L. Pilatre, P. Peyron, E. N. N'Diaye, V. Collart-Dutilleul, I. Maridonneau-Parini, and A. Diu-Hercend. 1999. The new ketolide HMR3647 accumulates in the azurophil granules of human polymorphonucelar cells. Antimicrob. Agents Chemother. 43:2457-2462.
23. Mtairag, E. M., H. Abdelghaffar, C. Douhet, and M. T. Labro. 1995. Role of extracellular calcium in in vitro uptake and intraphagocytic location of macrolides. Antimicrob. Agents Chemother. 39:1676-1682.
24. Mtairag, E. M., H. Abdelghaffar, and M. T. Labro. 1994. Investigation of dirithromycin and erythromycylamine uptake by human neutrophils in vitro. J. Antimicrob. Chemother. 33:523-536.
25. Muller-Serieys, C., J. Andrews, F. Vacheron, and C. Cantalloube. 2004. Tissue kinetics of telithromycin, the first ketolide antibacterial. J. Antimicrob. Chemother. 53:149-157.
26. Munic, V., M. Bosnar, Z. Kelneric, D. Zupanic, V. Erakovic, M. J. Parnham, and F. Damiani. 2002. Macrolide uptake and release by HL-60 and human polymorphonuclear (PMN) cells, abstr. 4.06, p. 120. In Program and abstracts of 6th Int. Conf. Macrolides, Azalides, Streptogramins, Ketolides and Oxazolidinones.
27. Namour, F., D. H. Wessels, M. H. Pascual, D. Reynolds, E. Sultan, and B. Lenfant. 2001. Pharmacokinetics of the new ketolide telithromycin (HMR 3647) administered in ascending single and multiple doses. Antimicrob. Agents Chemother. 45:170-175.
28. Pascual, A., S. Ballesta, I. García, and E. J. Perea. 2001. Uptake and intracellular activity of ketolide HMR 3647 in human phagocytic and non-phagocytic cells. Clin. Microbiol. Infect. 7:65-69.
29. Pascual, A., J. Rodriguez-Baño, S. Ballesta, I. García, and E. J. Perea. 1997. Azithromycin uptake by tissue cultured epithelial cells. J. Antimicrob. Chemother. 39:293-295.
30. Rodvold, K. A. 1999. Clinical pharmacokinetics of clarithromycin. Clin. Pharmacokinet. 37:385-398.
31. Rothen-Rutishauser, B., S. D. Krämer, A. Braun, M. Günthert, and H. Wunderli-Allenspach. 1998. MDCK cell cultures as an epithelial in vitro model: cytoskeleton and tight junctions as indicators for the definition of age-related stages by confocal microscopy. Pharm. Res. 15:964-971.
32. Segreti, J., P. Meyer, and K. Kapell. 1996. In vitro activity of macrolides against intracellular Legionella pneumophila. Diagn. Microbiol. Infect. Dis. 25:123-126.
33. Strigl, S., P. M. Roblin, T. Reznik, and M. R. Hammerschlag. 2000. In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae. Antimicrob. Agents Chemother. 44:1112-1113.
34. Vazifeh, D., H. Abdelghaffar, and M. T. Labro. 1997. Cellular accumulation of the new ketolide RU 64004 by human neutrophils: comparison with that of azithromycin and roxithromycin. Antimicrob. Agents Chemother. 41: 2099-2107.
35. Vazifeh, D., and M. T. Labro. 1999. Investigation of the uptake of HMR 3647, HMR 3004 and roxithromycin by myelomonocytic cell lines, abstr. 1929, p. 48. In Program abstr. 39th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, D.C.
36. Vazifeh, D., A. Preira, A. Bryskier, and M. T. Labro. 1998. Interactions between HMR 3647, a new ketolide, and human polymorphonuclear neutrophils. Antimicrob. Agents Chemother. 42:1944-1951.